176 related articles for article (PubMed ID: 2244593)
1. Quality assurance in gynecologic cytology. What is practical?
Rohr LR
Am J Clin Pathol; 1990 Dec; 94(6):754-8. PubMed ID: 2244593
[TBL] [Abstract][Full Text] [Related]
2. Chain of events in Papanicolaou smear testing: impact on quality assurance.
Genack LJ; Schumann GB
Diagn Cytopathol; 1989; 5(2):221-7. PubMed ID: 2550192
[TBL] [Abstract][Full Text] [Related]
3. 100% rapid (partial) rescreening for quality assurance.
Lemay C; Meisels A
Acta Cytol; 1999; 43(1):86-8. PubMed ID: 9987456
[TBL] [Abstract][Full Text] [Related]
4. Exfoliative cytologic screening. The Papanicolaou test.
Ginsberg CK
J Obstet Gynecol Neonatal Nurs; 1991; 20(1):39-46. PubMed ID: 2005483
[TBL] [Abstract][Full Text] [Related]
5. An approach to the problem of false negatives in gynecologic cytologic screening.
Hindman WM
Acta Cytol; 1989; 33(6):814-8. PubMed ID: 2686323
[TBL] [Abstract][Full Text] [Related]
6. The gynecologist's perspective of liability and quality issues with the Papanicolaou smear.
Greer BE
Arch Pathol Lab Med; 1997 Mar; 121(3):246-9. PubMed ID: 9111109
[TBL] [Abstract][Full Text] [Related]
7. A practical problem with calculating the false-negative rate of Papanicolaou smear interpretation by rescreening negative cases alone.
Renshaw AA
Cancer; 1999 Dec; 87(6):351-3. PubMed ID: 10603188
[TBL] [Abstract][Full Text] [Related]
8. Quality assurance in cervical cytology. The Papanicolaou smear. Council on Scientific Affairs.
JAMA; 1989 Sep 22-29; 262(12):1672-9. PubMed ID: 2671421
[No Abstract] [Full Text] [Related]
9. The role of monitoring interpretive rates, concordance between cytotechnologist and pathologist interpretations before sign-out, and turnaround time in gynecologic cytology quality assurance: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 1.
Clary KM; Davey DD; Naryshkin S; Austin RM; Thomas N; Chmara BA; Sugrue C; Tworek J
Arch Pathol Lab Med; 2013 Feb; 137(2):164-74. PubMed ID: 23368858
[TBL] [Abstract][Full Text] [Related]
10. Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening?
Kanber Y; Charbonneau M; Auger M
Cancer Cytopathol; 2015 Dec; 123(12):739-44. PubMed ID: 26348845
[TBL] [Abstract][Full Text] [Related]
11. The Pap smear: take two.
Shulman JJ; Hontz A; Sedlis A; Walters AT; Balin H; LoScuito L
Am J Obstet Gynecol; 1975 Apr; 121(8):1024-8. PubMed ID: 1119496
[TBL] [Abstract][Full Text] [Related]
12. Rescreening in cervical cytology for quality control. When bad data is worse than no data or what works, what doesn't, and why.
Renshaw AA
Clin Lab Med; 2003 Sep; 23(3):695-708. PubMed ID: 14560535
[TBL] [Abstract][Full Text] [Related]
13. Automation in cytology: a survey conducted by the New Technology Task Force, Papanicolaou Society of Cytopathology.
Masood S; Cajulis RS; Cibas ES; Wilbur DC; Bedrossian CW
Diagn Cytopathol; 1998 Jan; 18(1):47-55. PubMed ID: 9451558
[TBL] [Abstract][Full Text] [Related]
14. Quality-assurance study of simultaneously sampled, non-correlating cervical cytology and biopsies.
Dodd LG; Sneige N; Villarreal Y; Fanning CV; Staerkel GA; Caraway NP; Silva EG; Katz RL
Diagn Cytopathol; 1993; 9(2):138-44. PubMed ID: 8513706
[TBL] [Abstract][Full Text] [Related]
15. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.
Linder J; Zahniser D
Arch Pathol Lab Med; 1998 Feb; 122(2):139-44. PubMed ID: 9499356
[TBL] [Abstract][Full Text] [Related]
16. Trends in Cervical Cytology Screening and Reporting Practices: Results From the College of American Pathologists 2011 PAP Education Supplemental Questionnaire.
Crothers BA; Darragh TM; Tambouret RH; Nayar R; Barkan GA; Zhao C; Booth CN; Padmanabhan V; Tabatabai ZL; Souers RJ; Thomas N; Wilbur DC; Moriarty AT
Arch Pathol Lab Med; 2016 Jan; 140(1):13-21. PubMed ID: 26046490
[TBL] [Abstract][Full Text] [Related]
17. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
[TBL] [Abstract][Full Text] [Related]
18. Cytologic/histologic correlation for quality control in cervicovaginal cytology. Experience with 1,582 paired cases.
Joste NE; Crum CP; Cibas ES
Am J Clin Pathol; 1995 Jan; 103(1):32-4. PubMed ID: 7817940
[TBL] [Abstract][Full Text] [Related]
19. Random rescreening of cytologic smears: a practical and effective component of quality assurance programs in both large and small cytology laboratories.
Krieger P; Naryshkin S
Acta Cytol; 1994; 38(3):291-8. PubMed ID: 8191815
[No Abstract] [Full Text] [Related]
20. Internal quality assurance in cervical cytology one laboratory's experience.
Cross PA
Cytopathology; 1996 Feb; 7(1):25-31. PubMed ID: 8833871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
